Effectiveness of Focused Tele-education in Reducing Diabetes Complications During Ramadan

Sponsor
Sengkang General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06043843
Collaborator
Universiti Putra Malaysia (Other), Universiti Teknologi Mara (Other), Universiti Kebangsaan Malaysia Medical Centre (Other), University of Malaya (Other), Universiti Sains Malaysia (Other), Khoo Teck Puat Hospital (Other), Singapore General Hospital (Other), Changi General Hospital (Other)
300
1
2
63.4
4.7

Study Details

Study Description

Brief Summary

Introduction Diabetes is a global emergency with detrimental clinical and financial consequences. Poorly managed diabetes leads to a myriad of serious complications, especially cardiovascular and infectious complications, with consequent increased cost and mortality rate. For Muslims in particular, the annual fasting month of Ramadan is one such period when diabetes control is essential. Adequate adjustments in diabetes management need to be made in line with the allowed mealtimes to avoid the risk of diabetes complications during Ramadan.

Objective Investigators aim to investigate the effectiveness of Ramadan-focused structured diabetes tele-education to reduce diabetes complications during Ramadan fasting for Muslims with diabetes in South East Asia.

Methodology In a parallel group randomized controlled trial, investigators aim to recruit 300 adults with diabetes who are able to fast at least 15 days in Ramadan. You will be randomized to the intervention group comprising of a Ramadan-focused structured diabetes tele-education and control group receiving standard care. You will be reviewed again after Ramadan. The primary outcome is the incidence of hypoglycemia in Ramadan. The secondary outcomes are incidence of other diabetes complications in Ramadan episodes including hyperglycemia, episodes of acute infections, attendances in clinic and emergency department, hospital admissions, and compliance to recommendations for diabetes management during Ramadan.

Clinical Significance The study enables investigators to evaluate Ramadan-focused structured diabetes tele-education to reduce the risk of diabetes complications for a large population during the fasting month.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Focused diabetes tele-education and medication adjustment based on guidelines with remote monitoring from trial of fasting from before to throughout Ram
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Ramadan-focused Structured Diabetes Tele-education in Reducing Diabetes Complications During Ramadan Fasting in South East Asia
Actual Study Start Date :
Feb 16, 2021
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Jun 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Focused structured tele-education, medication adjustment and remote monitoring

Combination Product: Focused diabetes tele-education and medication adjustment based on guidelines with remote monitoring from trial of fasting from before to throughout Ram
Ramadan-focused online education by physician, specialist nurse, and dietitian via video conferencing Fasting and exemptions Self-monitoring of blood glucose Acute diabetes complications and treatment Ramadan nutritional plan Safe physical activity You will be taught to record Meal plans Physical activities Blood glucose monitoring, and Monitoring for diabetes complications Perform a trial fasting day prior to Ramadan. Medication adjustments will be made according to the Diabetes and Ramadan Alliance guideline as well as individualized modifications based on their HbA1c as follows Baseline HbA1c Recommended dose reduction < 8% 30% 8 to 10% 15% > 10% None 2) Glucose monitoring up to 4 times daily Before Ramadan for 1 week During Ramadan After Ramadan for 1 week uploaded into an online portal for data collection, without remote monitoring.

No Intervention: Control

Standard Care

Outcome Measures

Primary Outcome Measures

  1. Compare first incidence rate of hypoglycaemia or severe hypoglycemia between intervention and control groups in Ramadan [4 weeks]

Secondary Outcome Measures

  1. Compare the first incidence rate of hypoglycemia or severe hypoglycemia between intervention and control groups in Ramadan when compared to 4 weeks before and 4 weeks post-Ramadan [12 weeks]

  2. Compare the first incidence rate of other complications in Ramadan - hyperglycemia and crises, acute infections, clinic and emergency department attendances and hospital admissions [12 weeks]

  3. Compare the compliance to current Ramadan treatment recommendations for diabetes based on number of blood glucose monitoring during Ramadan [4 weeks]

  4. Compare the compliance to current Ramadan treatment recommendations for diabetes based on number of days of fast terminated in the event of hypoglycaemia or hyperglycemia [12 weeks]

  5. Compare the weight changes after Ramadan as compared to pre-Ramadan weight [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults with diabetes planning to fast in Ramadan,
  1. Adults with type 2 diabetes aged at least 21 years old,

  2. Able to fast at least 15 days in Ramadan based on experience of fasting in previous year's Ramadan,

  3. Underlying type 2 diabetes treated with basal insulin and one or more doses of prandial insulin, or at least twice-daily premixed insulin

  4. Performed laboratory tests as per standard care - glycated haemoglobin (HbA1c), serum Low Density Lipoprotein- cholesterol, serum triglycerides, serum High Density Lipoprotein- cholesterol, serum Total cholesterol and serum creatinine

  5. Ability to give informed consent,

  6. Ability to perform self-monitoring blood glucose

  7. Have had diabetes-related clinic visits or hospitalization in the past 10 months.

  8. Have the capacity for video conferencing (internet connection with mobile phone or computer)

Exclusion Criteria:
  1. Severe diabetes complications including end-stage renal failure

  2. Severe hypoglycemia and hyperglycemic crises within the last 3 months

  3. Advanced comorbidities negating the ability to fast

  4. Pregnancy

  5. Patients on oral medications alone or oral medications plus basal insulin alone

  6. Patients on sulfonylureas

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sengkang General Hospital Singapore Singapore

Sponsors and Collaborators

  • Sengkang General Hospital
  • Universiti Putra Malaysia
  • Universiti Teknologi Mara
  • Universiti Kebangsaan Malaysia Medical Centre
  • University of Malaya
  • Universiti Sains Malaysia
  • Khoo Teck Puat Hospital
  • Singapore General Hospital
  • Changi General Hospital

Investigators

  • Principal Investigator: Sueziani B Zainudin, Sengkang General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sengkang General Hospital
ClinicalTrials.gov Identifier:
NCT06043843
Other Study ID Numbers:
  • 2020/3137
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 21, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2023